AVERY W CATLIN
CIK 1255348 · Sr. VP & CFO · last filed 2024-06-03
AVERY W CATLIN is a Sr. VP & CFO who has filed 48 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for CRBP, was dated Sep 4, 2024. Across all open-market trades the lifetime net is +$196.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $38.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$38.0K
3
48
$196.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRBP | Director | 4,350 | $8.74 | $38.0K | $146.3K | 16 | 2024-06-03 |
| Provention Bio, Inc. (PRVB) Delisted | Director | 10,000 | $24.98 | $249.8K | $50.2K | 9 | 2023-04-27 |
| Celldex Therapeutics, Inc. (AVAND) Delisted | Sr. VP & CFO | — | — | — | $0 | 1 | 2008-03-11 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-04 | CRBP | Notice (144) | −888 | -$50.1K | EDGAR |
| 2024-06-03 | CRBP | Grant (A) | +2,783 | $0 | EDGAR |
| 2024-05-20 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2023-04-27 | Provention Bio, Inc. (PRVB) Delisted | Mixed | −20,000 | $0 | EDGAR |
| 2023-04-14 | Provention Bio, Inc. (PRVB) Delisted | Gift (G) | — | $0 | EDGAR |
| 2022-05-19 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2022-05-18 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | CRBP | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.